Jacques Tapiero
Director/Board Member at MCCORMICK & COMPANY, INCORPORATED
Net worth: 2 M $ as of 31/03/2024
Profile
Jacques Tapiero is an Independent Director at McCormick & Co., Inc. He is also a Director at Esteve Pharmaceuticals S.A.
and a Lead Director at Esteve Healthcare SL.
Additionally, he serves as a Member-Global Council at Thunderbird School of Global Management.
Previously, Jacques held positions such as Managing Director at Eli Lilly Sweden AB from 1993 to 1995, Senior Vice President & President-Emerging Markets at Eli Lilly & Co. from 1983 to 2014, President & General Manager at Eli Lilly do Brasil Ltda.
from 1995 to 1999, and President & General Manager at Lilly France SAS from 2000 to 2004.
Jacques obtained an MBA from Thunderbird School of Global Management in 1982.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 27/03/2024 | 27,755 ( 0.17% ) | 2 M $ | 31/03/2024 | |
| 27/03/2024 | 2,620 ( 0.00% ) | 201 242 $ | 31/03/2024 |
Jacques Tapiero active positions
| Companies | Position | Start |
|---|---|---|
| MCCORMICK & COMPANY, INCORPORATED | Director/Board Member | 24/09/2012 |
| Thunderbird School of Global Management | Corporate Officer/Principal | 05/05/2011 |
Esteve Pharmaceuticals S.A.
 Esteve Pharmaceuticals S.A. Pharmaceuticals: OtherHealth Technology Esteve Pharmaceuticals S.A. operates as a global pharmaceutical company. It provides Ophthalmology and other Pathologies therapies. The company is headquartered in Barcelona, Spain. | Director/Board Member | - |
Esteve Healthcare SL
 Esteve Healthcare SL Pharmaceuticals: MajorHealth Technology Esteve Healthcare SL is a Spanish international specialty pharma company that has experienced significant growth in 2022, expanding its presence in Europe and beyond. Esteve Healthcare is based in Barcelona, ES, and has subsidiaries in Germany. The company has launched an inhaled treatment for off periods in Parkinson's disease and is collaborating with Medtronic to improve the pathway of patients with refractory cancer pain. The company was founded in 1929 by Antoni Esteve Subirana, and Staffan Schüberg has been the CEO of the company since 2019. | Director/Board Member | 01/12/2016 |
Former positions of Jacques Tapiero
| Companies | Position | End |
|---|---|---|
| ELI LILLY AND COMPANY | Corporate Officer/Principal | 31/01/2014 |
Lilly France SAS
 Lilly France SAS Pharmaceuticals: GenericHealth Technology Lilly France SAS manufactures and supplies therapeutic products. The company is headquartered in Neuilly-sur-Seine, France. | Chief Executive Officer | 01/01/2004 |
Eli Lilly do Brasil Ltda.
 Eli Lilly do Brasil Ltda. Pharmaceuticals: MajorHealth Technology Eli Lilly do Brasil Ltda. manufactures medicines. Its products include medicines for cancer, diabetes, depression, osteoporosis, and others. The company was founded in 1944 and is headquartered in Sao Paulo, Brazil. | Chief Executive Officer | 01/01/1999 |
| Eli Lilly Sweden AB | Chief Executive Officer | 01/01/1995 |
Training of Jacques Tapiero
| Thunderbird School of Global Management | Masters Business Admin |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 2 |
|---|---|
| ELI LILLY AND COMPANY | Health Technology |
| MCCORMICK & COMPANY, INCORPORATED | Consumer Non-Durables |
| Private companies | 5 |
|---|---|
Eli Lilly do Brasil Ltda.
Eli Lilly do Brasil Ltda. Pharmaceuticals: MajorHealth Technology Eli Lilly do Brasil Ltda. manufactures medicines. Its products include medicines for cancer, diabetes, depression, osteoporosis, and others. The company was founded in 1944 and is headquartered in Sao Paulo, Brazil. | Health Technology |
Lilly France SAS
Lilly France SAS Pharmaceuticals: GenericHealth Technology Lilly France SAS manufactures and supplies therapeutic products. The company is headquartered in Neuilly-sur-Seine, France. | Health Technology |
| Eli Lilly Sweden AB | |
Esteve Pharmaceuticals S.A.
Esteve Pharmaceuticals S.A. Pharmaceuticals: OtherHealth Technology Esteve Pharmaceuticals S.A. operates as a global pharmaceutical company. It provides Ophthalmology and other Pathologies therapies. The company is headquartered in Barcelona, Spain. | Health Technology |
Esteve Healthcare SL
Esteve Healthcare SL Pharmaceuticals: MajorHealth Technology Esteve Healthcare SL is a Spanish international specialty pharma company that has experienced significant growth in 2022, expanding its presence in Europe and beyond. Esteve Healthcare is based in Barcelona, ES, and has subsidiaries in Germany. The company has launched an inhaled treatment for off periods in Parkinson's disease and is collaborating with Medtronic to improve the pathway of patients with refractory cancer pain. The company was founded in 1929 by Antoni Esteve Subirana, and Staffan Schüberg has been the CEO of the company since 2019. | Health Technology |
- Stock Market
- Insiders
- Jacques Tapiero
